Navigation Links
FDAnews Announces Medical Device Mobile Apps Virtual Conference - Oct. 3, 2013
Date:9/19/2013

FALLS CHURCH, Va., Sept. 19, 2013 /PRNewswire-iReach/ -- Medical Device Mobile Apps
The Biosense Case: FDA Sends First Warning
**FDAnews Virtual Conference**
Oct. 3, 2013 — 10:00 a.m. – 4:00 p.m. EDT
www.fdanews.com/MDMobileAppsVC  

(Photo: http://photos.prnewswire.com/prnh/20130919/MN82966)

Smartphone technology opens a new world for medical device innovation. It also opens a can of worms with the FDA. Could you get in trouble?

A smartphone app that can analyze urine is a really smart app. Indeed, it isn't an app at all: It's a medical device.

Or is it? That's the question troubling devicemakers everywhere, now that the FDA has made an example of Biosense.

Biosense markets an app called uCheck that checks urine levels of blood, protein and other substances, using dipsticks and an iPhone camera to record and analyze results. The dipsticks are OK; it's the dipstick-plus-phone combo that's the problem. Together, asserts the FDA, they constitute a new medical device.

The line between app and regulated medical device has been blurry since 2011, when the FDA issued its first draft guidance. Now, everyone from app designers to Congress is awaiting the final guidance, expected this fall.

Meantime … what do you do?

Here's a great first step: Register now for the one-day virtual conference, Medical Device Mobile Apps.

FDAnews has invited an authoritative FDA voice, Baku Patel of CDRH, plus four top private-sector lawyers and devicemakers for an intensive one-day virtual conference examining this fast-changing area where innovation and regulation collide.

Speakers will lay out how the FDA approaches regulation of mobile medical apps, then tease out the fine points that can mean the difference between FDA approval and a warning letter. You'll discover:

  • What the FDA means when it uses the word health vs. wellness
  • What the FDA concept of intended use signifies
  • What constitutes an accessory, and which accessories does the FDA regulate?
  • Implications of the Biosence letter and the FDA's thinking going forward
  • The FDA's checklist for a successful approval — best practices and red flags every devicemaker must know
  • Obtaining FDA clearance — identifying and addressing safety-and-effectiveness criteria
  • The future of mobile medical apps: How you can work with the FDA to best serve patients
  • And much more

From fast-changing technology to regulatory parameters, conference chair Tim Gee is ideally positioned to shed light on the complexities. Mr. Gee boasts more than 20 years of in-depth research and experience helping medical device firms manage connectivity, and developing and obtaining FDA approval for medical-device apps.

Smartphone apps hold immense promise for devicemakers — and thorny new areas of regulation and law too, as the Biosense matter illustrates. On your way to innovation, don't let regulatory hazards trip you up. Get the answers you need — now.

Register now

Meet Your Faculty

  • Tim Gee, Principal and Founder of Medical Connectivity Consulting and a principal consultant with Santa Rosa Consulting. He boasts more than 25 years' experience with workflow automation via integration of medical devices with information systems and enabling technologies. Clients include healthcare providers, manufacturers and early-stage companies. Mr. Gee is 2012 recipient of the American College of Clinical Engineering's Challenger Award.
  • Brad Thompson, Member, Epstein Becker & Green; General Counsel, mHealth Regulatory Coalition 
  • Bakul Patel, Senior Policy Advisor to the Center Director, CDRH, FDA (invited)
  • Kyle Peterson, Director, Regulatory & Corporate Affairs, Calgary Scientific
  • Marian Lee, Partner, King and Spalding

Who Should Attend

  • Product development teams
  • Research and design teams
  • Legal and regulatory affairs
  • Risk management and design operations
  • Manufacturing
  • R&D and engineering
  • QA/QC staff
  • Compliance officers
  • Executive management
  • Outside counsel

Conference Details
Medical Device Mobile Apps
The Biosense Case: FDA Sends First Warning
**FDAnews Virtual Conference**
Oct. 3, 2013 — 10:00 a.m. – 4:00 p.m. EDT
www.fdanews.com/MDMobileAppsVC 

Tuition
$1,297 per site -- includes virtual conference registration and audio cds and transcripts

Easy Ways to Register
Online:      www.fdanews.com/MDMobileAppsVC
By phone: 888-838-5578 or 703-538-7600
 

Media Contact: Jeff Grizzel, FDAnews, 703-538-7600, jgrizzel@fdanews.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE FDAnews
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDAnews Announces The Insiders Guide to Supplier Quality Success DVD
2. FDAnews Announces Leading the Climb: Seven Essentials of GMP Workshop
3. FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
4. FDAnews Announces Clinical Quality Assurance Workshop
5. FDAnews announces Biopharmaceutical Good Distribution Practices Summit
6. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
7. FDAnews announces Third Annual Pharmaceutical Labeling Summit
8. FDAnews Announces Medical Device Mobile Apps Virtual Conference
9. FDAnews announces Fourth Annual Supplier Quality Congress
10. Pro-Dex, Inc. Announces Fiscal 2013 Fourth Quarter And Full-Year Financial Results Conference Call And Webcast
11. Rafarma Pharmaceuticals, Inc. (RAFA) announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/3/2017)...  Eli Lilly and Company (NYSE: ... Phase 3 MONARCH 2 study showed that abemaciclib, ... combination with fulvestrant, significantly improved progression-free survival (PFS) ... with hormone-receptor-positive (HR+), human epidermal growth factor receptor ... or progressed after endocrine therapy (median PFS, 16.4 ...
(Date:5/30/2017)... 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading global ... announced that it will be presenting at the 7th annual LD ... Erez Raphael , CEO, of DarioHealth will be giving the ... held on June 6th & 7th, 2017 at the Luxe Sunset ... / micro-cap space. About LD ...
Breaking Medicine Technology:
(Date:6/28/2017)... NE (PRWEB) , ... June 28, 2017 , ... ... Medical has been recognized for excellence in employee engagement. Omaha-based C&A ... the Achievers 50 Most Engaged Workplaces™ in North America for 2017. ...
(Date:6/28/2017)... ... June 28, 2017 , ... Anyone with a remote control has seen the never-ending ... it, you the flipper will get rich in no time. But what about the ... can get for the buyer of a flipped house. An email recently sent to ...
(Date:6/28/2017)... ... ... Park Systems , a leader in Atomic Force Microscopy (AFM) since ... Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear Brewing Company. ... Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the School of ...
(Date:6/28/2017)... ... June 28, 2017 , ... The ... throughout the greater Cincinnati metropolitan area, is teaming up with the local chapter ... with children receiving treatment in nearby hospitals. , Ronald McDonald House of Greater ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):